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Abstract
Background: Neuronatin (NNAT) is an endoplasmic reticulum proteolipid implicated in intracellular signalling. Nnat is
highly-expressed in the hypothalamus, where it is acutely regulated by nutrients and leptin. Nnat pre-mRNA is differentially
spliced to create Nnat-a and -b isoforms. Genetic variation of NNAT is associated with severe obesity. Currently, little is
known about the long-term regulation of Nnat.
Methods: Expression of Nnat isoforms were examined in the hypothalamus of mice in response to acute fast/feed, chronic
caloric restriction, diet-induced obesity and modified gastric bypass surgery. Nnat expression was assessed in the central
nervous system and gastrointestinal tissues. RTqPCR was used to determine isoform-specific expression of Nnat mRNA.
Results: Hypothalamic expression of both Nnat isoforms was comparably decreased by overnight and 24-h fasting. Nnat
expression was unaltered in diet-induced obesity, or subsequent switch to a calorie restricted diet. Nnat isoforms showed
differential expression in the hypothalamus but not brainstem after bypass surgery. Hypothalamic Nnat-b expression was
significantly reduced after bypass compared with sham surgery (P = 0.003), and was positively correlated with post-
operative weight-loss (R2 = 0.38, P = 0.01). In contrast, Nnat-a expression was not suppressed after bypass surgery (P = 0.19),
and expression did not correlate with reduction in weight after surgery (R2 = 0.06, P = 0.34). Hypothalamic expression of
Nnat-b correlated weakly with circulating leptin, but neither isoform correlated with fasting gut hormone levels post-
surgery. Nnat expression was detected in brainstem, brown-adipose tissue, stomach and small intestine.
Conclusions: Nnat expression in hypothalamus is regulated by short-term nutrient availability, but unaltered by diet-
induced obesity or calorie restriction. While Nnat isoforms in the hypothalamus are co-ordinately regulated by acute
nutrient supply, after modified gastric bypass surgery Nnat isoforms show differential expression. These results raise the
possibility that in the radically altered nutrient and hormonal milieu created by bypass surgery, resultant differential splicing
of Nnat pre-mRNA may contribute to weight-loss.
Citation: Scott WR, Gelegen C, Chandarana K, Karra E, Yousseif A, et al. (2013) Differential Pre-mRNA Splicing Regulates Nnat Isoforms in the Hypothalamus after
Gastric Bypass Surgery in Mice. PLoS ONE 8(3): e59407. doi:10.1371/journal.pone.0059407
Editor: Thomas W.H. Kay, St. Vincent’s Institute, Australia
Received July 17, 2012; Accepted February 17, 2013; Published March 20, 2013
Copyright:  2013 Scott et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Rosetrees Trust (http://www.rosetreestrust.co.uk/) and the National Institute for Health Research University College
London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: r.batterham@ucl.ac.uk
Introduction
Obesity is defined as excess body fat deposition and is a
considerable global healthcare challenge. The World Health
Organisation estimates that there are currently two billion obese
or overweight adults worldwide [1]. Obesity is a leading risk factor
for the development of type 2 diabetes, cardiovascular disease,
cancer and dementia [2,3,4]. As the adoption of a Western energy-
dense diet and sedentary lifestyle increases, particularly in low- and
middle-income societies, the prevalence of obesity and burden of
its complications are set to rise dramatically [5]. To compound
this, available lifestyle and pharmaceutical therapies for obesity are
ineffectual [6,7], and bariatric surgery, the only effective and
durable treatment, is reserved for the morbidly obese [8].
Excess body fat deposition occurs when energy intake from diet
chronically outweighs energy expenditure [9]. Homeostatic
centres in the hypothalamus and brainstem regulate appetite
and energy expenditure according to short- and long-term signals
of energy flux emanating from gastrointestinal, hepatic, pancreatic
and adipose tissue, and from simultaneous higher order cortical
cues [9,10]. Within this multi-organ system a variety of genetic,
molecular and physiological defects have been causally linked to
obesity [11,12,13,14,15], however the precise biological mecha-
nisms that favour long-term energy storage remain poorly
characterised. Importantly, certain bariatric procedures like gastric
bypass surgery lead to potent changes in appetite and energy
expenditure with highly significant and durable weight-loss
[16,17,18], most likely as a result of changes in gut hormones,
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such as ghrelin, peptide-YY (PYY) and glucagon-like peptide 1
(GLP1), as well as changes in neuronal and nutrient signals, that
appear to override these intrinsic defects [8]. A greater under-
standing of the key regulators within this homeostatic circuitry and
how they are modified after particular bariatric operations will be
critical in the development of targeted strategies for the prevention
and treatment of obesity.
Neuronatin (NNAT) is a paternally expressed imprinted gene
residing within a large intron of the bladder cancer associated
protein (BLCAP) gene [19,20], variations in which are implicated
in extremes of childhood and adult obesity [21]. The gene encodes
two isoforms, NNAT-a of 81 and NNAT-b of 54 amino acids,
derived by alternative splicing of the middle of three coding exons
which eliminates a transmembrane domain [22]. Based upon
shared sequence homology to proteolipids both isoforms are
thought to regulate intracellular signalling via the endoplasmic
reticulum (ER) calcium ATPase [23,24]. In murine models, Nnat is
primarily concerned with antenatal brain growth and develop-
ment [22,23,25]. Nnat-a is expressed earlier than Nnat-b in
gestational development implying isoform-specific regulation and
function [22].
Recent studies also implicate Nnat in nutrient signalling and
energy homeostasis. In mouse hypothalamus, Nnat expression is
reduced following 48-h fast, specifically in the arcuate nucleus,
dorsomedial hypothalamic nucleus (DMN), lateromedial hypotha-
lamic nucleus and paraventricular nucleus (PVN) [21,26]; is
increased following peripheral administration of the satiety
hormone leptin, though this is restricted to the DMN and PVN
[21]; and co-localises in neurones containing important mediators
of appetite control, including MCH, orexin and CART [21]. Thus
hypothalamic Nnat expression is responsive to acute nutrient and
leptin signalling in a neurone-specific fashion, and may mediate
intracellular signalling to determine appetite.
In white adipose tissue (WAT), Nnat is over-expressed in obese
and high-fat fed murine models, and is under-expressed in
lipodystrophic and lean S6kko mice, as well as in mice fed
conjugated linoleic acid to induce weight loss [27,28,29,30]. In the
pancreas, Nnat is expressed at high levels in islets cells [31,32],
where it is a target of the NeuroD1 a transcription factor that is
important for neuronal and endocrine cell differentiation and
survival [30,33]. In vitro, Nnat expression is associated with calcium-
induced 3T3-L1 cell adipogenesis [28]; activation of PI3k, Erk,
mTor and calcium signalling in medulloblastoma cells [34]; Nfkb-
regulated inflammation in aortic endothelial cells [35]; and
protection against mitochondrial toxins and ionophors in PC12
cells [36]. Similarly, in b-cell lines Nnat expression is associated
with glucose-stimulated, calcium-induced insulin secretion [24,33],
whilst overexpression of the b-isoform may be concerned with ER
stress and b-cell apoptosis [24]. In bioinformatic analyses, Nnat
expression is highly correlated with expression of genes concerned
with energy metabolism in the hypothalamus and WAT, in
particular oxidative phosphorylation, and with inflammation in
WAT alone [30].
Although previous studies may suggest a role for Nnat in acute
appetite and energy homeostasis and in metabolic-inflammation
the physiological function(s) of Nnat remain largely unknown.
Further, there is limited data on the total or differential expression
of Nnat isoforms in metabolic tissues in response to either acute or
chronic changes in nutrient signalling. We therefore undertook
studies to investigate the isoform-specific regulation of Nnat in the
hypothalamus in response to acute nutrient fasting, high-fat diet-
induced obesity, chronic dietary caloric restriction and modified
gastric bypass surgery. These states were selected to represent a
broad range of short- and long-term hormonal, nutrient and
neuronal signals of energy flux, with the potential to regulate
hypothalamic Nnat expression. We also examined expression of
Nnat isoforms in other metabolic tissues involved in energy
regulation.
Results
Nnat Expression in Central Nervous System (CNS),
Adipose Tissue and Gastrointestinal (GI) Tract
In adult mice both Nnat-a and -b isoforms were highly expressed
in hypothalamus and WAT (Table 1). We also demonstrated
abundant expression of both isoforms in brainstem, modest
expression in brown adipose tissue (BAT), stomach and jejunum,
and low expression in duodenum and ileum (Table 1). Relative
Nnat-a and -b expression in all tissues under all conditions
(including diet studies below) showed positive correlation (Figure 1;
R2 = 0.35, P,0.001).
Figure 1. Relative expression between Nnat isoforms in
metabolic tissues. Nnat-a expression was positively correlated with
Nnat-b expression when compared in the hypothalamus and brainstem,
white and brown adipose tissue, and stomach, duodenum, jejunum and
ileum, implying shared and distinct regulatory factors (n = 229).
doi:10.1371/journal.pone.0059407.g001
Table 1. Tissue Nnat expression.
Nnat-a Nnat-b
Hypothalamus 0.55 0.47
Brainstem 0.30 0.25
WAT 0.28 0.17
BAT 0.0050 0.0031
Stomach 0.0029 0.0023
Duodenum 0.00075 0.00016
Jejunum 0.0066 0.017
Ileum 0.00093 0.00099
RNA was extracted from tissue for n = 4 mice and pooled for measurement of
Nnat expression; Nnat expression was standardised relative to ubiquitin (Ubc)
expression (Nnat-a or -b/Ubc).
doi:10.1371/journal.pone.0059407.t001
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Effect of Acute Nutritional Regulation on Nnat Expression
We confirmed the influence of acute feeding state on global
hypothalamic Nnat expression. Mean Nnat-a and -b expression
levels were reduced in the fasted compared to ad-libitum fed state.
This did not reach significance after overnight fast (Figure 2A; t
test P= 0.397, P = 0.055; Nnat-a and -b respectively), but became
highly significant after 24-h fast (Figure 2B; t test P = 0.005,
P = 0.007; Nnat-a and -b respectively). In stomach and duodenum,
mean expression did not differ significantly between overnight fast
and ad-libitum fed groups, for either Nnat-a or -b (Figures 2C and
2D).
Effect of Diet-induced Obesity (DIO) on Hypothalamic
Nnat Expression
Adult mice fed high-fat diet for 4, 8, 12 and 16 weeks developed
DIO. Final body-weight, increase in body-weight, and plasma
leptin were significantly different in DIO groups compared to
control groups maintained on standard dietary chow, except at
week 4 for final body weight and week 8 for circulating leptin
where the difference did not reach significance (Figure S1 A–C;
Table S1). Body-weight increased between 4, 8, 12 and 16 weeks
DIO, but less rapidly after 8 weeks (Figure S1A & S1B; Table S1;
ANOVA overall significance levels P= 0.0001 for both final body-
weight and delta body-weight). The difference in plasma leptin
levels at different time points of DIO was overall significant
(ANOVA overall significance level P= 0.038, though post-hoc
comparisons did not show a significant difference between
Figure 2. Expression of Nnat isoforms in response to fasting versus ad-libitum feeding. A) Hypothalamic Nnat-a and -b showed a non-
significant reduction in response to overnight fasting (n = 10) when compared to ad-libitum fed counterparts (n = 10); B) but a significant reduction
after 24-h fasting (n = 10) compared to feeding (n = 11), equivalent for both isoforms (**Nnat-a P= 0.005, **Nnat-b P= 0.007); C–D) Nnat isoforms did
not show a consistent or significant change after overnight fasting in the stomach or duodenum (n= 10 fasted, n = 10 ad-libitum fed in both tissues);
key – AU=arbitrary units where Nnat expression was standardised using ubiquitin (Ubc) as a reference gene.
doi:10.1371/journal.pone.0059407.g002
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different time points). Mean global hypothalamic Nnat expression
did not differ either between tiers of DIO or in comparison to
controls, for either Nnat-a or -b (Figure S1D and S1E).
Effect of Caloric Restriction on Hypothalamic Nnat
Expression
Mice with DIO and normal-weight counterparts were subjected
to 4 weeks of caloric restriction. DIO mice were either maintained
on high-fat diet, or switched to a diet of standard chow or caloric
restriction. Normal-weight controls were exposed to equivalent
dietary switches. This resulted in significant differences in final
body-weight and change in body-weight between both DIO and
control groups (Table 2A and 2B; DIO dietary switches, ANOVA
overall significance P= 0.0001 for both final and delta body-
weight; Control dietary switches, ANOVA overall significance
P=0.0001 for both final and delta body-weight). Fasting
circulating plasma leptin was also significantly different in the
DIO and control groups (Table 2A and B; DIO and Control
dietary switches, ANOVA overall significance P=0.0001). Mean
hypothalamic Nnat-a and -b expression did not differ between
DIO mice maintained on a high-fat diet, or switched to a diet of
standard chow or calorie restricted (Figure S2A and S2B).
Similarly, mean hypothalamic Nnat expression was comparable
between control groups with parallel dietary switches (Figure S2A
and S2B) and also did not differ when compared to the DIO
groups, for either Nnat-a or -b (Figure S2A and S2B). Nnat isoforms
showed no correlation with either weight reduction or fasting
leptin after dietary caloric restriction (Nnat-a weight-loss R2 = 0.08,
P = 0.08; leptin R2= 0.05, P= 0.19; Nnat-b weight-loss R2 = 0.03,
P = 0.29; leptin R2= 0.05, P= 0.69).
Differential Hypothalamic Nnat Expression after Bariatric
Surgery, and Correlation Analyses
DIO mice subjected to modified gastric bypass surgery
exhibited marked reduction in food intake throughout the post-
operative period; food intake in sham mice reduced initially then
returned to baseline pre-operative levels by post-operative Day 5
(Figure S3). Mice after bypass lost more weight and weighed
significantly less at 10 days post-surgery compared to sham mice
(Table 3). Fasting plasma leptin was significantly lower in the
bypass versus sham group, whilst circulating fasting levels of the
gut hormones acyl-ghrelin, total PYY and active-GLP1 were
significantly higher (Table 3). Nnat isoforms showed differential
expression in hypothalamus after bypass surgery (Figure 3A).
Hypothalamic Nnat-b expression was significantly reduced after
bypass compared with sham surgery (Figure 3A; t test P = 0.003).
Nnat-a expression was not (Figure 3A; t test P= 0.188). Nnat-a
expression did not correlate with reduction in weight after surgery
(Figure 4A; R2= 0.06, P= 0.34) or fasting plasma leptin (Figure 4B;
R2= 0.23, P = 0.38). However, Nnat-b showed positive correlation
with weight reduction after surgery (Figure 4C; R2= 0.38,
P= 0.01) and weak correlation with fasting leptin concentration
(Figure 4D; R2= 0.27, P = 0.06). Neither Nnat isoform correlated
with circulating fasting levels of the gut hormones acyl-ghrelin,
total PYY and active-GLP1 after surgery (Table S2). Nnat
expression was also analysed in the brainstem after bariatric and
sham surgery. In brainstem Nnat-a and –b did not differ between
bypass and sham counterparts (Figure 3B; t test P= 0.56, P = 0.51;
Nnat-a and -b respectively).
Discussion
Our key new finding is that Nnat isoforms are regulated by
differential pre-mRNA splicing in the hypothalamus after modi-
fied gastric bypass surgery. We found that hypothalamic Nnat-b
expression is significantly reduced after bypass compared with
sham surgery, and is correlated with weight reduction and to a
lesser extent with circulating fasting leptin after surgery. Alterna-
tively, Nnat-a expression is unaltered after bypass compared to
sham-operated mice and does not correlate with weight reduction
or fasting plasma leptin. We found no relationship between fasting
gut hormones and hypothalamic Nnat expression after surgery. In
the brainstem expression of Nnat-a and -b is comparable after
bypass and sham surgery. In the analogous experimental situation
of dietary caloric restriction hypothalamic Nnat does not reduce
either in total or differential expression, despite comparable total
weight-loss and circulating leptin levels. Likewise, overall or
differential expression of Nnat in the hypothalamus does not alter
during the development of DIO. In contrast, Nnat-a and -b
isoforms are comparably suppressed in the hypothalamus after an
over-night and 24-h fast.
Table 2. Change in body weight and leptin after chronic dietary switches.
Control Control-HF Control-CR HF-control HF HF-CR
Body weight (g) 28.8 (0.7) 33.6 (0.9) 20.5 (0.5) 30.5 (0.9) 35.1 (1.9) 26.2 (0.6)
Delta body weight (g) 21.9 (0.4) 1.7 (0.4) 28.0 (0.7) 24.3 (0.7) 21.3 (0.6) 210.6 (1.1)
Leptin (ng/ml) 1.13 (0.16) 6.06 (0.16) 0.29 (0.05) 1.26 (0.25) 7.29 (1.91) 0.37 (0.08)
Final body-weight
(P value)
Delta change in body-weight
(P value)
Final plasma leptin
(P value)
Control vs. Control-HF 0.0001* 0.0001* 0.01*
Control vs. Control-CR 0.0001* 0.0001* 0.001*
Control-HF vs. Control-CR 0.0001* 0.0001* 0.01*
HF-control vs. HF 0.1 0.07 0.04*
HF-control vs. HF-CR 0.0001* 0.0001* 0.02*
HF vs. HF-CR 0.0001* 0.0001* 0.02*
Control = standard dietary chow maintained, Control-HF = standard dietary chow switch to high-fat diet, Control-CR = standard dietary chow switch to caloric restriction;
HF-Control = high-fat diet switch to standard dietary chow, HF =high-fat diet maintained, HF-CR = high-fat diet switch to caloric restriction; data presented as P value
(post-hoc ANOVA).
doi:10.1371/journal.pone.0059407.t002
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Differential expression of Nnat isoforms has been demonstrated
previously, both during embryogenesis and in neuroendocrine cell
lines. Nnat-a is first expressed in the brain of the mouse embryo at
the time of neuroepithelial proliferation (embryonic days 7–10),
whilst Nnat-b is expressed later during neurogenesis (embryonic
days 11–14) [22]. In a murine pancreatic beta-cell line (MIN6)
transfected with addition copies of the Nnat gene, the Nnat-b to
Nnat-a ratio is increased proportionately to both glucose concen-
tration and to length of glucose exposure [24]. The function of
Nnat isoforms was tested in MIN6 cells by over-expression. At high
glucose concentrations over-expression of Nnat-b induced ER
stress and decreased the expression of genes important for beta-cell
function, glucokinase (Gck), pancreas duodenum homeobox-1 (Pdx-
1), and insulin [24]. Nnat-a did not have these effects [24]. Pdx1
encodes a transcription factor necessary for pancreatic develop-
ment and b-cell maturation. Pdx1 is expressed in the developing
neuroendocrine pancreas at a similar time to Nnat in the brain
[37]. These reports indicate different roles for Nnat-a and Nnat-b in
growth and differentiation during development, and in nutrient
responsiveness within differentiated cells. Our observations, taken
together with these previous findings, raise the possibility that
factors within the milieu of signalling changes accompanying
bypass may lead to suppression of the Nnat-b isoform through
differential splicing of Nnat pre-mRNA. This in turn may alter
neuroendocrine function in the hypothalamus in support of
weight-loss.
Surgical reorganisation of gut anatomy causes changes in
nutrient partitioning and absorption, with resultant adaptation of
gut-derived hormonal, neuronal and nutrient signals. These
signals are known to act in the hypothalamus, as well as in the
brainstem and other CNS regions, and are considered in part to
mediate the weight loss changes observed post-surgery [8]. We
found no link between fasting gut hormone levels and differential
hypothalamic expression of Nnat isoforms. This makes it unlikely
that ghrelin, which acts to increase appetite primarily in the fasted
state, plays a major role. Neither meal-stimulated gut hormone
levels nor neuronal and nutrient signals were assessed; however all
could mediate differential Nnat expression. Of note, post-prandial
changes in PYY and GLP-1 show greater modification compared
to fasted levels after bypass surgery [8]. Such changes could play a
regulatory role if acting through a delayed mechanism, for
example by direct or indirect modification of gene expression.
Alternatively, differential expression of Nnat isoforms in the
hypothalamus may reflect changes in body-weight or food intake
specific to bypass surgery. Total weight-loss per-se is unlikely to be
responsible as we found similar total weight-loss after bypass and
dietary caloric restriction, and Nnat expression was independent of
weight-loss after dietary caloric restriction. However, mice at day
10 post-bypass are in an anorectic and accelerated weight-loss
phase, whereas mice undergoing chronic dietary caloric restriction
show more gradual weight reduction and exhibit increased
hunger. These differences in energy status might mediate
differential expression of Nnat isoforms after bypass; though this
would appear to be hypothalamus-specific as brainstem expression
is not comparably altered. Of note, circulating leptin is secreted
proportionate to adipose tissue mass but also in relation to
dynamic energy status irrespective of adipose tissue mass [38]. We
observed equivalent circulating leptin levels after bypass surgery
and dietary caloric restriction. Together these observations suggest
that differences in energy balance do not fully account for
differential effects on hypothalamic Nnat isoforms after bypass
surgery.
Hypothalamic Nnat expression was assessed after overnight and
24-h fasts, compared to ad-libitum feeding; both Nnat isoforms
showed a comparable modest reduction in expression after
overnight fast and a larger reduction after 24-h fast. Published
work has shown reduction in hypothalamic Nnat expression in
response to prolonged 48-h fast [21,26], and that leptin
administration acutely increases Nnat in the DMH and PVN
[21]. Previous studies find that Nnat expression is unaffected
following 24-h fast in the cerebellum [26], a stress responsive tissue
not concerned with energy balance, supporting the view that the
changes in Nnat mRNA in the hypothalamus are a direct response
to changes in nutrient or leptin signalling.
We investigated the effect of chronic high-fat feeding and DIO
on hypothalamic Nnat expression and found no effect, despite
significant differences in body-weight and circulating leptin
between DIO and control mice. Thus, chronic nutrient excess
and elevations in circulating leptin do not appreciably determine
global hypothalamic Nnat expression, and hypothalamic Nnat
Figure 3. Hypothalamic and brainstem Nnat expression after
modified gastric bypass versus sham surgery. A) Nnat-b showed a
significant reduction in the hypothalamus (**P = 0.003) after modified
gastric bypass (n = 8) compared to sham surgery (n = 7) whilst Nnat-a
did not reduce significantly, consistent with a bypass-specific effect on
Nnat-b expression; B) expression of Nnat-a and Nnat-b did not differ in
the brainstem after modified gastric bypass (n = 8) compared to sham
surgery (n = 7); key – GBP=modified gastric bypass surgery, Sham= sham
surgery, AU= arbitrary units where Nnat expression was standardised
using an endogenous reference gene (ubiquitin (Ubc) for hypothalamus,
hypoxanthine guanine phosphoriboribosyl transferase (Hprt) for brain-
stem).
doi:10.1371/journal.pone.0059407.g003
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expression is not perturbed in this model of obesity. Hypothalamic
leptin resistance has been shown to develop as early as day 16 in
DIO mice [39], and this may abrogate a leptin-dependent effect
on hypothalamic Nnat expression in this model. Alternatively, we
may miss hypothalamic nucleus-specific changes in Nnat expres-
sion since we examine only whole hypothalamus. These findings
contrast with other metabolic tissues such as WAT and aortic
endothelial cells where Nnat expression is increased in obesity and
diabetes [30,35].
The effect of chronic dietary caloric restriction on hypothalamic
Nnat expression was also examined in mice with DIO and in
normal-weight counterparts. We found no difference in Nnat
expression in response to caloric restriction for either Nnat isoform,
despite differences in final body-weight, change in body-weight
and circulating leptin levels. In contrast to acute caloric restriction
Figure 4. Isoform-specific Nnat expression in the hypothalamus after surgery in relation to weight-loss and circulating leptin. A–B)
Nnat-a expression in the hypothalamus did not correlate with either change in body-weight or with circulating leptin after surgery; C–D) by contrast
Nnat-b expression showed positive correlation with change in body-weight and weak positive correlation with circulating leptin after surgery; key –
Nnat-a expression shown with open squares, Nnat-b with filled circles, AU= arbitrary units where Nnat expression was standardised using ubiquitin (Ubc)
as a reference gene.
doi:10.1371/journal.pone.0059407.g004
Table 3. Changes in body-weight, leptin and gut hormones after surgery.
Final body-
weight (g)
Change in body-
weight (g)
Plasma leptin
level (ng/ml)
Plasma acyl-
ghrelin level
(pmol/l)
Plasma total PYY
level (pmol/l)
Plasma active-
GLP1 level (pmol/l)
GBP surgery (n =8) 24.5 (1.2) 211.4 (1.3) 0.27 (0.07) 1179 (258) 29.0 (5.1) 10.5 (2.9)
Sham surgery (n=7) 31.1 (1.4) 24.8 (0.6) 1.05 (0.23) 517 (83) 13.1 (1.8) 2.3 (0.4)
GBS vs. Sham (P value) 0.003* 0.0007* 0.004* 0.03* 0.01* 0.02*
GBP=modified gastric bypass surgery; data presented as Mean (Standard Error of Mean) or P value (t test).
doi:10.1371/journal.pone.0059407.t003
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and modified gastric bypass surgery, chronic dietary caloric
restriction leading to weight-loss with reductions in circulating
leptin level has no appreciable effect on global hypothalamic Nnat
expression. Importantly, these findings include mice with normal
starting body-weight and intact hypothalamic leptin signalling,
implying that hypothalamic leptin resistance does not account for
unchanged Nnat expression either after chronic caloric restriction
or in DIO.
To investigate the wider function of Nnat we examined its
expression in a broad range of metabolic tissues. We identified
Nnat expression at high levels in brainstem, substantial levels in
BAT, stomach and jejunum, and lower levels in duodenum and
ileum, and confirmed published results showing high levels of Nnat
expression in WAT. When we compared relative expression of
Nnat isoforms in these metabolic tissues we found modest positive
correlation between Nnat-a and -b, suggesting potential differential
isoforms expression in these tissues too. The role of overnight fast
on Nnat expression in the stomach and duodenum was examined
as these tissues have key acute nutrient sensing and signalling
functions. No difference was found in stomach or duodenal Nnat
expression after overnight fast when compared to ad-libitum fed
counterparts; the role of 24-h fast was not examined in the absence
of a directional effect equivalent to that found in the hypothal-
amus. While the overall functional significance of Nnat isoforms in
metabolic tissues is likely to relate to total tissue expression levels,
this may underestimate the local impact of Nnat within specialised
neuroendocrine cells. This may be important in the GI tract, as in
the pancreas, where neuroendocrine cells make up only a small
proportion of total tissue and are the expected location of Nnat
[31,32]. The effect of acute fast on Nnat expression in the GI tract
will need to be re-examined using localising techniques in
enteroendocrine cells.
Our studies have several limitations. We focus on isoform-
specific regulation of Nnat pre-RNA in global hypothalamus in
response to states of acute and chronic energy flux, but do not
investigate hypothalamic nucleus-specific changes in Nnat, or
confirm our findings with protein expression. We also do not
investigate in detail other brain regions involved in energy
regulation. Our results demonstrate differential expression of
hypothalamic Nnat isoforms after gastric bypass surgery. However,
this finding is associative and the relative contribution of bypass-
specific and other indirect factors remains to be established. We
are able to make mechanistic inferences but do not delineate
underlying biological mechanisms. Future studies are therefore
required to localise changes in Nnat pre-RNA and protein isoforms
in hypothalamic nuclei after bariatric surgery, DIO and dietary
caloric restriction, as well as in other metabolic tissues, and to
investigate precise causal processes within cellular systems and
transgenic models.
Summary and Conclusion
In the hypothalamus we demonstrate for the first time that
differential pre-mRNA splicing preferentially suppresses Nnat-b in
response to modified gastric bypass surgery, but not in response to
the analogous situation of dietary caloric restriction. We further
show that global Nnat expression is reduced in response short-term
fast in the hypothalamus, though comparably for both isoforms.
No effect on Nnat mRNA was discovered in response to chronic
caloric excess and DIO. Our results indicate that the Nnat gene
expression has shared (i.e. RNA transcription or turnover) and
isoform-specific regulatory factors (i.e. differential pre-mRNA
splicing). In addition our studies provide the first evidence that
both Nnat isoforms are expressed in a broad range of metabolically
active tissues, where the effect of nutritional status now needs to be
examined further. Whilst the functional determinants of Nnat
expression in the hypothalamus remain unclear, our findings raise
the possibility that Nnat could mediate changes in appetite and
energy expenditure during fasting/feeding and after bariatric
surgery, via intracellular signalling changes. This position is
strengthened by previously published work, which demonstrates
co-localisation of Nnat in neuronal cells specifically expressing
functional mediators of appetite control and energy expenditure
[21]. Our study adds Nnat to the group of genes in which
differential pre-mRNA splicing coordinates protein isoforms
expression with potentially meaningful physiological consequences
[40].
Materials and Methods
In vivo Studies
All studies were performed in accordance with the Home Office
Animal Procedures Act, UK (1986), project license PPL70/6648,
and guidelines established by the European Convention for the
Protection of Laboratory animals. All animals comprised male
C57BL/6 mice (from Charles River U.K. Ltd), maintained in a
pathogen-free environment at constant temperature with free
water access, and subjected to 12-h light/dark cycle (0700–1900-
h). Diets were obtained from Research Diets, New Brunswick, NJ
USA (details specified below). Weight measurements were made
using precision weighing balance (Sartorius, GE), accurate to
0.01 g.
For baseline expression studies in homeostatic tissues, adult
mice without regulatory pre-conditions were used (n= 4, aged 8–
16 weeks).
For acute nutritional studies, adult mice aged 8 weeks were
randomised to ad-libitum standard dietary chow (composition 70%
carbohydrate, 10% fat, 20% protein; Research Diets Catalogue
D12450B), overnight fast (14-h duration) and 24-h fast groups
(n = 10, n= 10, n = 11 respectively). All fasted mice were pre-
conditioned, and experienced equivalent duration fast then re-
feeding on three prior occasions.
For chronic high-fat diet and DIO studies, adult mice aged 8
weeks were randomised to ad-libitum high-fat diet (composition
35% carbohydrate, 45% fat, 20% protein; Research Diets
Catalogue D12451) or standard dietary chow (composition above)
groups, n= 40 in both. Body-weight was monitored weekly. After
4, 8, 12 and 16 weeks respectively ten mice from each dietary
group were killed after 16-h fast. 16-h fasts were carried out in all
chronic dietary studies (DIO; chronic dietary modulation with
dietary switch; bariatric surgery) prior to termination. This
minimises the confounding effect of acute feeding state, as systemic
gut hormone levels may remain elevated up to 12-h after nutrient
intake [41,42].
For chronic dietary modulation with dietary switch studies,
adult mice aged 8 weeks were randomised to ad-libitum high-fat
diet (n = 30) and ad-libitum standard dietary chow (n= 30). After 16
weeks high-fat diet (DIO) mice were then randomised to one of
three groups: i) maintained on this diet (n = 10); ii) switched to ad-
libitum standard dietary chow (n = 10); or iii) switched to step-down
caloric restriction (n = 10). Similarly control diet mice were
randomised to one of three groups: i) maintained on standard
dietary chow (n= 10); ii) switched to high-fat diet (n = 10); or iii)
switched to step-down caloric restriction (n= 10). These diets were
maintained for a further 4 weeks then mice were killed after 16-h
fast. Body-weight was monitored weekly. Calorie restriction was
carried out by step-down regime [43,44]. Food intake and body-
weight were assessed on a daily basis in DIO and control mice
both maintained on ad-libitum standard dietary chow, to obtain
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measurements of food consumed per gram of body-weight. These
measurements were then used to calculate food intake in DIO
mice switched to caloric restriction and in control mice switched to
caloric restriction respectively. For the step-down caloric restric-
tion, an 80% restriction was applied in week 1, with 60%
restriction in weeks 2–4. Food was given at onset of the dark phase
(19.00-h) to maintain circadian rhythms.
For the bariatric surgery studies, adult mice aged 6 weeks were
fed ad-libitum high-fat diet for 18 weeks, and then acclimatised for
one week. After matching for body-weight, mice were assigned to
modified gastric bypass or sham surgery (n = 8 for both groups).
Procedures were carried out as previously described [45,46].
Modified gastric bypass surgery comprised a midline laparotomy,
ligature of the pyloric sphincter, and entero-gastric anastomosis
between stomach fundus and mid-jejunum, thus excluding
duodenum and proximal jejunum. Sham surgery comprised
midline laparotomy, intestinal exposure and intestinal manipula-
tion without transection, with duration corresponding to the
bypass group. Daily post-operative monitoring for well-being was
provided. One mouse in the sham group died post-operatively. On
post-operative day 10 mice were re-weighed then killed, after a 16-
h fast. This time point was selected for evaluation of factors
contributing to weight-loss, rather than those resulting from
marked changes in body-weight. Posthumously, the pyloric
ligation was checked and was intact for all bypass subjects.
Blood and Tissue Collection
Mice were killed using terminal anaesthesia. Blood was sampled
by cardiac puncture using 29-gauge needle and syringe, after
exposure of the chest cavity. For measurement of active GLP-1,
dipeptidyl peptidase-IV inhibitor [10 ml/ml of blood] (Millipore,
Watford, UK), was drawn into a chilled syringe before blood
collection. For all other hormones blood was collected into an
empty chilled syringe. Blood was transferred from syringes to tubes
containing 0.5 M EDTA [50 ml/ml of blood], and aprotinin,
[5000 Kallikrein inhibitor units (KIU)/ml of blood] (Trasylol;
Bayer, UK). All samples were kept on ice until processing. Blood
tubes were centrifuged for 15-mins at 10,000 rpm at 4uC. Plasma
was aspirated by pipette and transferred to empty eppendorfs. For
measurement of acyl-ghrelin, plasma was acidified by addition of
50 ml of 1 N hydrochloric acid per ml and 10 ml, 4-(2-
Aminoethyl)-benzenesulfonyl fluoride hydrochloride (Fluka, Dor-
set, UK) 100 mg/ml was added to retard ex-vivo degradation. All
samples were stored at 280uC until analysis.
All tissues were rapidly dissected and collected in cryovials
(Nunc; Thermo Fisher, Roskilde, Denmark), then snap frozen in
liquid nitrogen for storage at -80uC. Interscapular BAT and
inguinal WAT were dissected. Stomach was divided from
oesophagus and duodenum. The entire alimentary tract was
removed from the body and fully extended. For duodenum, the
first 3 cm of duodenum distal to the pyloric sphincter was
dissected, a 3 cm section of jejunum (15 cm from the pyloric
sphincter) was dissected, a 3 cm section of ileum proximal to the
ileo-caecal valve. GI tissue was cleared of peritoneum and
contents. After decapitation brain was removed. Hypothalamus
and brainstem were dissected. The limits of the hypothalamus for
dissection were: i) optic chiasma at the anterior border; ii)
mammillary bodies at the posterior border; iii) the hypothalamic
sulci at both lateral sides. Hypothalamic tissue was finally cut
dorsally at 2 mm from the ventral face. Brainstem blocks were
composed of pons and medulla regions of the hind brain and
excluded cerebellum; dissection of the block started cranially at the
level of intersection between midbrain and pons, and finished
caudally at the level of intersection between pons and spinal cord.
Nnat mRNA Expression using RTqPCR
Total RNA (tRNA) was extracted from homogenised whole
tissue (including brainstem, hypothalamus, WAT, BAT, stomach,
duodenum, jejunum and ileum) using a commercial extraction
system (TRIzol reagent protocol). Quantity of RNA was measured
using Nanodrop spectrometer, and integrity assessed by analysis of
A260/A280 ratios. A two-tube technique was used for real-time
quantitative PCR (RTqPCR). 2 ml of tRNA was reverse
transcribed into cDNA under optimal conditions using Taqman
reverse transcriptase reagents (Applied Biosystems, UK). RTqPCR
was performed using proprietary sequence specific Taqman Gene
Expression Assay FAM/TAMARA probes, specific for Nnat-a,
Nnat-b, ubiquitin (Ubc) and hypoxanthine guanine phosphoribor-
ibosyl transferase (Hprt), on an AbiPrism 7000HT instrument
utilising automatically selected Ct values. Ubc was chosen as an
endogenous reference gene to normalise expression data and
account for differences in efficiency in all conditions except
brainstem. In brainstem Hprt was used as the endogenous
reference gene because of significant differences in Ubc expression
between study groups. Target-specific standard curves were
performed using 2-4-fold serial dilutions of template tRNA from
tissue samples under investigation, and analysed to confirm
efficiency, reproducibility and sensitivity, and to quantify the
unknowns. Sample hypothalamic cDNA was diluted 1:8, brain-
stem cDNA 1:6, and stomach and duodenum cDNA 1:5, to fit
these standard curves. All samples were analysed in duplicate, with
negative controls.
Hormone Assays
Plasma leptin was measured as a marker of adiposity and
chronic nutritional state. Plasma concentrations of leptin and
active-GLP1 were measured using commercially available ELISA
kits (Millipore, Watford, UK). Plasma acyl-ghrelin and total PYY
were measured using commercially available radioimmunoassay
(Millipore, Watford, UK). All samples were tested in duplicate.
Statistics
For all expression studies, results were expressed as mean and
standard error of the mean. Comparisons between Nnat expres-
sion, final body-weight, changes in body-weight and plasma leptin,
were made using non-paired Student’s t test for comparing the
means of two groups, and using one-way ANOVA for comparing
the means of three or more groups. For one-way ANOVA post-
hoc tests were performed in case a significant effect was detected
(Bonferroni correction was used when the equality of variances
assumption held, and Dunnett t3 correction was used otherwise).
Significance was established at P,0.05. Linear regression analyses
were performed to compare relationships between two continuous
variables.
Supporting Information
Figure S1 Body-weight, circulating leptin and hypotha-
lamic Nnat expression in response to diet-induced
obesity. A–C) Final body-weight, (delta) increase in body-weight,
and plasma leptin were significantly different after 4, 8, 12, 16
weeks of high-fat feeding compared to control groups, except at
week 4 for final body-weight and week 8 for plasma leptin where
the difference did not reach significance; D-E) neither Nnat-a or -b
expression was altered in the hypothalamus after 4, 8, 12, 16 weeks
of high-fat feeding, either sequentially or compared to controls, key
– HF= high-fat diet, Control = standard dietary chow.
(TIF)
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Figure S2 Hypothalamic Nnat expression in response to
dietary caloric restriction. A–B) Nnat-a and -b isoforms were
equivalently expressed in DIO mice either maintained on high-fat
diet or switched to standard dietary chow or caloric restriction,
and in controls undergoing equivalent switches; key – Control
(standard dietary chow throughout, n = 10), Control-CR (standard dietary
chow for 16 weeks then step-down caloric restriction for 4 weeks, n = 10),
Control-HF (standard dietary chow for 16 weeks then switch to high-fat diet
for 4 weeks, n = 10), HF (high-fat diet throughout, n = 10), HF-Control
(high-fat diet for 16 week then switch to standard dietary chow for 4 weeks,
n = 10) and HF-CR (high-fat diet for 16 weeks then step-down caloric
restriction for 4 weeks, n = 10); AU= arbitrary units where Nnat expression
was standardised using ubiquitin (Ubc) as a reference gene.
(TIF)
Figure S3 Food intake after modified gastric bypass
versus sham surgery. Mean 24-h caloric intake was signifi-
cantly suppressed at Day 2 after surgery compared to pre-surgery
baseline, in both bypass and sham groups; in the bypass group
mean daily intake remained comparably suppressed up to day of
termination (Day 10); by contrast, in the sham group mean daily
intake returned to pre-surgery baseline by Day 5, and remained at
this level until termination; food intake between the two groups
was significantly different from Day 2; key – circles show mean food
intake (g) per 24-h period in the modified gastric bypass group, squares show
food mean intake (g) per 24-h period in the ad-libitum fed sham control group,
standardised for mean body-weight (g); * ** *** represent P,0.05, ,0.01,
,0.001 respectively for within group comparisons; ### represents
P,0.001 for between group comparisons.
(TIF)
Table S1 Changes in body-weight and leptin in control
and DIO mice.
(DOCX)
Table S2 Correlation of Nnat isoform expression and
fasting gut hormone measures.
(DOCX)
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